Literature DB >> 6238599

Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthritis.

R M Pope, L McChesney, N Talal, M Fischbach.   

Abstract

In order to characterize the autologous mixed lymphocyte response (AMLR) in patients with rheumatoid arthritis (RA) and to define the relationship with disease activity, peripheral blood T lymphocytes were stimulated with either a B lymphocyte-enriched (B cells) or a macrophage-enriched (macrophages) population. A significant reduction (P less than 0.01 to P less than 0.001) of T cell proliferation stimulated both by B cells and macrophages was observed in patients with active disease. The B lymphocytes were significantly less stimulatory (P less than 0.02 to P less than 0.001) than macrophages in the patients compared with the controls. In the normal controls, macrophages in higher concentrations were capable of suppressing the B lymphocyte-stimulated AMLR, but macrophages from patients with RA were not excessively suppressive. A significant association (P less than 0.02) was observed between disease activity and the AMLR. Using the B-enriched population, the AMLR proliferative response was significantly associated (P less than 0.001) with the production of interleukin-2. Defects in proliferation could only be partially restored by the addition of interleukin-2. These data indicate that the defective AMLR observed in patients with RA is related to disease activity and is associated with altered cellular interactions among T lymphocytes, macrophages, and the B lymphocyte-enriched population.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238599     DOI: 10.1002/art.1780271105

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Impaired autologous mixed lymphocyte reaction (AMLR) reactivity of peripheral blood T cell subsets in rheumatoid arthritis.

Authors:  E C Keystone; L Poplonski; K M Snow; M Martell
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen.

Authors:  D A Fox; J A Millard; L Kan; W S Zeldes; W Davis; J Higgs; F Emmrich; R W Kinne
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  T cell interactions in active rheumatoid arthritis: insights from the human autologous mixed lymphocyte reaction as a model of T cell activation cascade.

Authors:  T Sakane; Y Murakawa; M Takeno; T Shigeki; H Nagafuchi; T Miki
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

4.  Expression and function of CD5 and CD28 in patients with rheumatoid arthritis.

Authors:  J Verwilghen; V Corrigall; R M Pope; R Rodrigues; G S Panayi
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

5.  Lymphokine-activated killer cell activity in rheumatoid arthritis.

Authors:  M Jíra; M Malkovský; A M Denman; B Loveland; D Lyons; A G Dalgleish; A D Webster
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

6.  The distribution and functional properties of dendritic cells in patients with seronegative arthritis.

Authors:  A J Stagg; B Harding; R A Hughes; A Keat; S C Knight
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

7.  IL-2 production in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.

Authors:  K Oen; R Warrington; A M Rosenberg; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.